- $188.77m
- $185.57m
- $21.20m
- 47
- 20
- 89
- 51
2019 December 29th | 2021 January 3rd | 2022 January 2nd | 2023 December 31st | 2023 January 1st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10.3 | 8.63 | 12.7 | 21.2 | 16.2 |
Cost of Revenue | |||||
Gross Profit | 5.91 | 4.25 | 7.42 | 14.5 | 8.8 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 25.7 | 19.5 | 19 | 21.1 | 20 |
Operating Profit | -15.4 | -10.9 | -6.32 | 0.07 | -3.8 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -15.5 | -11.1 | -6.5 | -0.261 | -4.17 |
Provision for Income Taxes | |||||
Net Income After Taxes | -15.4 | -11.2 | -6.62 | -0.263 | -4.27 |
Net Income Before Extraordinary Items | |||||
Net Income | -15.4 | -11.2 | -6.62 | -0.263 | -4.27 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -15.4 | -11.2 | -6.62 | -0.263 | -4.27 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.02 | -1.09 | -0.641 | -0.02 | -0.339 |